Noveris Health Sciences Inc. MYCOF
0.80 USD +0.07 (+9.59%)
At closeOct 30, 2026, 4:00 PM EDT
0.80 Day range 0.80
0.096 52-week range 2.04
- YTD
- +266.97%
- 1 year
- +238.98%
News
newsfilecorp.com Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces the results of its…
newsfilecorp.com Noveris Health Sciences Announces Proposed Private Placement of Convertible Debentures for up to $500,000 Vancouver, British Columbia--(Newsfile Corp. - August 20, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") is pleased to announce its…
newsfilecorp.com Noveris Health Sciences Receives USPTO Notice of Allowance, and Signs Work Order with API Vancouver, British Columbia--(Newsfile Corp. - August 18, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) ("Noveris" or the "Company") is pleased to announce that the…
newsfilecorp.com Noveris Health Sciences Inc. Unaware of Any Material Change Vancouver, British Columbia--(Newsfile Corp. - August 6, 2026) - At the request of CIRO, Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") wishes to…
newsfilecorp.com Noveris Health Sciences Joins BioAlberta Vancouver, British Columbia--(Newsfile Corp. - July 30, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces that it has become a…
thenewswire.com Noveris Health Sciences Joins the Biotechnology Innovation Organization (BIO) VANCOUVER, BC, Canada – TheNewswire - July 17, 2026 — Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) (“Noveris” or the “Company”) is pleased to announce that it has joined the…
thenewswire.com Noveris Health Sciences Joins Life Sciences BC VANCOUVER, BC, Canada – TheNewswire - July 14, 2026 — Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) ("Noveris" or the "Company") is pleased to announce that, effective July 13,…
thenewswire.com Noveris Health Sciences Announces Upcoming AGM and Record Date, and receipt of CSE Notice VANCOUVER, BC, Canada – TheNewswire - June 29, 2026 — Noveris Health Sciences Inc. (CSE: NVRS; FSE: 0NF0; OTC: MYCOF) (“ Noveris ” or the “ Company ”) is pleased to announce that its annual general…
thenewswire.com Noveris Health Sciences Announces Appointment Of Nathan Mison As Chair Of Advisory Board Vancouver, British Columbia – June 12, 2026 – TheNewswire – Noveris Health Sciences Inc. (“Noveris” or the “Company”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) is pleased to announce the appointment of…
thenewswire.com Noveris Health Sciences Appoints Geoff Griffiths As Strategic Advisor To Support Commercialization And Growth Initiatives VANCOUVER, British Columbia, JUNE 8, 2026 - TheNewswire – Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) (“Noveris” or the “Company”) is pleased to announce the appointment of…
thenewswire.com Noveris Health Sciences Provides Corporate Update VANCOUVER, BC, Canada, June 5, 2026 – TheNewswire — Noveris Health Sciences Inc. (CSE: NVRS | FSE: 0NF0 | OTC: MYCOF) (“Noveris” or the “Company”) is pleased to provide this corporate update.…
thenewswire.com Noveris Health Sciences Provides Corporate Update, and Announces Agreement for Acquisition of Stem Cell Distribution Business Vancouver, British Columbia – TheNewswire - April 29, 2026 – Noveris Health Sciences Inc. (the “ Company ”, or “ Noveris ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) wishes to provide a corporate update.…
thenewswire.com Noveris Health Sciences Inc. Announces Signing Of Market Making Advisory Agreement With DS Market Solutions Inc. Vancouver, British Columbia, April 22, 2026 - TheNewswire – Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) is pleased to announce that it has entered into an…
thenewswire.com Noveris Health Sciences Inc. Provides Clarifying News Release Regarding Life Offering And Other Disclosure Vancouver, British Columbia, April 20, 2026 – TheNewswire – Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces that, as a result of a review by the British…
thenewswire.com Noveris Provides Announces Trading Halt Order, And Clarification As To Article Vancouver, British Columbia, March 26, 2026 – TheNewswire – Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces that the British Columbia Securities…
thenewswire.com Noveris Announces Closing of Life Offering Vancouver, British Columbia – TheNewswire - March 18, 2026 – Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) is pleased to announce that it has completed its…
thenewswire.com Noveris Health Sciences Inc. Unaware Of Any Material Change Vancouver, British Columbia, March 16, 2026 – TheNewswire - At the request of CIRO, Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) wishes to confirm that the…
thenewswire.com Noveris Health Sciences Launches Investor Website and Engages Fairfax Partners Inc. for Investor Relations and Digital Marketing Services VANCOUVER, BC – TheNewswire - March 13, 202 6 – Noveris Health Sciences Inc. ( CSE: NVRS ) ( FSE: 0NF0 ) ( OTC: MYCOF ) (the " Company ") is pleased to announce the launch of its new investor-facing…
thenewswire.com Noveris Announces Resignation Of CEO Vancouver, British Columbia, March 10, 2026 – TheNewswire — Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces today that Joshua Bartch has resigned as…
thenewswire.com Noveris Announces Conversion Of Debentures; Filing Of Early Warning Reports By JJK Holdings Ltd. And Joshua Bartch Vancouver, British Columbia, March 6, 2026 — TheNewswire - Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces today the conversion of debentures in the…